Tate & Lyle PLC
Tate & Lyle Value Added Seminar
Tate & Lyle PLC will be holding a seminar focussing on its Value Added strategy
today in London, commencing at 9.45 am. The meeting will be hosted by Iain
Ferguson, Chief Executive, and other senior executives and will be attended by
institutional investors and stockbrokers' analysts.
Stanley Musesengwa, Chief Operating Officer, will provide an overview of Tate &
Lyle's business and value added products and will explain the contribution that
value added products make to overall profitability.
Peter Boynton, Senior Vice President, Industrial Ingredients, will give an
update on industrial starches and bio-products.
Austin Maguire, President of Tate & Lyle Sucralose, will update on current
trading in the division and the progress of the expansion projects in Alabama
and Singapore.
Mark White, President of the Global Food Ingredients Group, will set out the
Group's approach to consumer understanding and will give examples of successful
collaboration with Tate & Lyle's customers which has resulted in new product
launches.
In his conclusion, Iain Ferguson will comment on current trading and will
reaffirm the statement made at the Annual General Meeting on 19 July 2006 that
we continue to view the future with confidence and remain committed to our
target for the profit contribution from total value added products to increase
by 30% in the year to March 2007 from the £161 million reported last year.
The presentations given at the seminar will be available on our website
(www.tateandlyle.com), after the start of the meeting.
Timing of Trading Update
In line with its regular practice, Tate & Lyle will issue a trading update on
2 October 2006, when entering a closed period in respect of the interim results
to 30 September 2006. In addition to the announcement, a conference call for
analysts and investors will be held at 9.30 am on 2 October. The call will be
hosted by Iain Ferguson, Chief Executive, John Nicholas, Group Finance Director
and Mark Robinson, Director of Investor Relations. Dial in details will be
published shortly.
The interim results will be announced on 2 November 2006.
ctor of Investor Relations
Tel: 020 7626 6525 or Mobile: 07793 515861
Ferne Hudson, Head of Media and Public Relations
Tel: 020 7626 6525
About Tate & Lyle:
Tate & Lyle is a world leading manufacturer of renewable food and industrial
ingredients. It uses innovative technology to transform corn, wheat and sugar
into value-added ingredients for customers in the food, beverage,
pharmaceutical, cosmetic, paper, packaging and building industries. The Company
is a leader in cereal sweeteners and starches, sugar refining, value added food
and industrial ingredients, and citric acid. Tate & Lyle is the world number-one
in industrial starches and is the sole manufacturer of SPLENDA® Sucralose.
Headquartered in London, Tate & Lyle is listed on the London Stock Exchange
under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company
operates more than 65 production facilities in 29 countries, throughout Europe,
the Americas and South East Asia. It employs 7,000 people in its subsidiaries
with a further 4,800 employed in joint ventures. Sales in the year to 31 March
2006 totalled £3.7 billion. Additional information can be found on this website
www.tateandlyle.com.
SPLENDA® is a trademark of McNeil Nutritionals, LLC
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.